EUROFINS SCIENT Net Profit Margin 2018-2023 | ERFSF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

EUROFINS SCIENT net profit margin from 2018 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

EUROFINS SCIENT net profit margin from 2018 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$124.8B
Cencora (COR)	$44.6B
ICON (ICLR)	$24.8B
DiDi Global (DIDIY)	$19.2B
Avantor (AVTR)	$18.8B
Natera (NTRA)	$15.7B
Revvity (RVTY)	$15.6B
Viatris (VTRS)	$14.2B
CochLear (CHEOY)	$12.7B
Solventum (SOLV)	$12.5B
Medpace Holdings (MEDP)	$11.4B
Charles River Laboratories (CRL)	$10.8B
Sonic Healthcare (SKHHY)	$8.8B
Doximity (DOCS)	$7.5B
Bausch + Lomb (BLCO)	$7B
HealthEquity (HQY)	$6.9B
PACS (PACS)	$6.3B
Organon (OGN)	$5.2B
Life Times (LTH)	$5B
Sotera Health (SHC)	$4.7B
Surgery Partners (SGRY)	$4.2B
Concentras Parent (CON)	$2.9B
GoodRx Holdings (GDRX)	$2.7B
BrightSpring Health Services (BTSG)	$2.6B
Ardent Health Partners (ARDT)	$2.6B
Alignment Healthcare (ALHC)	$2.2B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$1.9B
AMN Healthcare Services Inc (AMN)	$1.7B
Agilon Health (AGL)	$1.6B